Furthermore, aromatase levels can vary in heterogeneous cells populations, with the contribution of aromatase in normal breast changing in magnitude with the development of a tumor [27] and, hence, increasing the local bioavailability of estrogen. The gene discussed is CYP19A1; the disease is neoplasm.